Turkish Society of Pediatric Gastroenterology, Hepatology and Nutrition
1
Clinical Trials at Acıbadem Altunizade Hastanesi; Oncology
During the past decade, Acıbadem Altunizade Hastanesi; Oncology conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Acıbadem Altunizade Hastanesi; Oncology" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Acibadem University" with 2 trials
sponsored, "Diskapi Teaching and Research Hospital" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Turkish Society of Pediatric Gastroenterology, Hepatology and Nutrition"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Acıbadem Altunizade Hastanesi; Oncology"
#1 collaborator was "Jazz Pharmaceuticals" with 1 trials as a collaborator, "The Scientific and Technological Research Council of Turkey" with 1 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Acıbadem Altunizade Hastanesi; Oncology
According to Clinical.Site data, the most researched conditions in "Acıbadem Altunizade Hastanesi; Oncology" are
"Blood Transfusion" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Anemia" (1 trials), "Blood Loss Anemia" (1 trials) and "Blood Loss, Surgical" (1 trials). Many other conditions were trialed in "Acıbadem Altunizade Hastanesi; Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Acıbadem Altunizade Hastanesi; Oncology
Most popular intervention types in "Acıbadem Altunizade Hastanesi; Oncology" are "Drug" (5 trials), "Other" (2 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Blood transfusion" (2 trials), "Carboplatin" (1 trials), "Control" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Acıbadem Altunizade Hastanesi; Oncology
The vast majority of trials in "Acıbadem Altunizade Hastanesi; Oncology" are
10 trials for "All" genders.
Clinical Trials Status at Acıbadem Altunizade Hastanesi; Oncology
Currently, there are NaN active trials in "Acıbadem Altunizade Hastanesi; Oncology".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Acıbadem Altunizade Hastanesi; Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Acıbadem Altunizade Hastanesi; Oncology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".